New York § 3328 Exemptions from title

New York Statutes

§ 3328 — Exemptions from title

New York § 3328

Law PBHPublic Health

Title 3Research, Instructional Activities, and Chemical Analysis Relating to Controlled Substances

Art. 33Controlled Substances

This text of New York § 3328 (Exemptions from title) is published on Counsel Stack Legal Research, covering New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.Y. Public Health § 3328 (2026).

Text

  § 3328. Exemptions from title.  The following persons engaging in the\nfollowing activities shall be exempt from the provisions of this title:\n  1. A practitioner lawfully administering, dispensing, or prescribing a\ncontrolled substance in the course of his professional practice to an\nultimate user for a recognized medical purpose;\n  2. A licensed manufacturer engaged in research upon non-human subjects\nor chemical analysis conducted on the premises specified in the\nmanufacturer's license;\n  3. A licensed distributor engaged in quality control analysis at the\npremises specified in his license.\n  4. A practitioner or patient participating in a clinical research\nprogram on the therapeutic use of marijuana or tetrahydrocannabinols.\n(a) Each such clinical research program shall ha

Free access — add to your briefcase to read the full text and ask questions with AI

§ 3328. Exemptions from title. The following persons engaging in the\nfollowing activities shall be exempt from the provisions of this title:\n 1. A practitioner lawfully administering, dispensing, or prescribing a\ncontrolled substance in the course of his professional practice to an\nultimate user for a recognized medical purpose;\n 2. A licensed manufacturer engaged in research upon non-human subjects\nor chemical analysis conducted on the premises specified in the\nmanufacturer's license;\n 3. A licensed distributor engaged in quality control analysis at the\npremises specified in his license.\n 4. A practitioner or patient participating in a clinical research\nprogram on the therapeutic use of marijuana or tetrahydrocannabinols.\n(a) Each such clinical research program shall have received protocol\napproval from the United States Food and Drug Administration, shall\npossess an effective investigational new drug application and shall have\nbeen registered by the Drug Enforcement Administration, United States\nDepartment of Justice.\n (b) Each such clinical research program authorized under the\nprovisions of article thirty-three-A of this chapter.\n